• Advertise
  • Contact Us
  • Daily The Business
  • Privacy Policy
Friday, December 5, 2025
Daily The Business
  • Login
No Result
View All Result
DTB
No Result
View All Result
DTB

FDA-Only Products: Punjab’s Centralised Tender Conditioning Ignites Controversy

May 31, 2024
in Business
FDA-Only Products: Punjab’s Centralised Tender Conditioning Ignites Controversy
Share on FacebookShare on TwitterWhatsapp

The Punjab government has recently stipulated that only FDA-approved cardiac disposables and consumables will be eligible for procurement bids, a decision that has sparked controversy within the medical supply industry. This move excludes numerous suppliers from Europe, China, and Japan who have been previously approved by Pakistan’s Drug Regulatory Authority (DRAP).

In a tender document issued by the Specialized Healthcare and Medical Education Department of Punjab, the government has invited bids specifically from suppliers capable of providing FDA-approved products necessary for heart surgeries in public hospitals.

While aimed at ensuring stringent quality standards in cardiac care, this requirement has drawn criticism from suppliers who are DRAP-approved but do not meet the FDA criteria.

The decision is part of a broader effort to centralize the procurement process across major healthcare institutes in Punjab, including the Punjab Institute of Cardiology and Multan Institute of Cardiology.

Typically, tenders are issued independently by each hospital, allowing fair competition among suppliers. However, the centralization has been questioned for its selective pre-qualification and technical requirements that favor a limited number of companies.

Concerns have been raised regarding the transparency and fairness of this procurement process, with allegations of favoritism towards US FDA-approved brands. Critics argue that the move could potentially create a monopoly in the market, restrict patient choice, and exclude new entrants from participating in the bidding process.

Dr. Asim Javed, a member of the Specialized Healthcare and Medical Education Department Government of Punjab, defended the decision, stating it was made in the best interest of patients.

He clarified that while certain cardiac supplies are now limited to FDA-approved products, other suppliers are not completely disqualified and can still provide other types of medical supplies. He emphasized that the government’s priority is to ensure patients receive the highest quality of care, and suppliers will continue to fulfill the required supplies.

Efforts to obtain comments from Special Secretary and Additional Secretary of the department were unsuccessful, highlighting ongoing challenges in obtaining further insights into the decision-making process behind this controversial policy shift.

Tags: CentralisedConditioningControversyFDAOnlyIgnitesProductsPunjabsTender
Share15Tweet10Send
Previous Post

Palm oil rises on export outlook; books weekly gain

Next Post

Copper extends losses after weak factory data from China

Related Posts

Bullish momentum at bourse, KSE-100 gains over 1,100 points in early trade
Business

Bullish momentum at bourse, KSE-100 gains nearly 900 points during intra-day

December 5, 2025
World’s top solar maker says local manufacturing not yet viable in Pakistan
Business

World’s top solar maker says local manufacturing not yet viable in Pakistan

December 5, 2025
US stocks lower after mixed jobs data
Business

US stocks lower after mixed jobs data

December 4, 2025
Saudi Arabia extends term for $3bn deposit placed with Pakistan for another year
Business

Saudi Arabia extends term for $3bn deposit placed with Pakistan for another year

December 4, 2025
Pakistan, Kyrgyzstan sign agreements to strengthen bilateral cooperation
Business

Pakistan, Kyrgyzstan sign agreements to strengthen bilateral cooperation

December 5, 2025
Intra-day update: rupee records gain against US dollar
Business

Intra-day update: rupee records gain against US dollar

December 4, 2025

Popular Post

  • FRSHAR Mail

    FRSHAR Mail set to redefine secure communication, data privacy

    126 shares
    Share 50 Tweet 32
  • How to avoid buyer’s remorse when raising venture capital

    33 shares
    Share 337 Tweet 211
  • Microsoft to pay off cloud industry group to end EU antitrust complaint

    54 shares
    Share 22 Tweet 14
  • Capacity utilisation of Pakistan’s cement industry drops to lowest on record

    47 shares
    Share 19 Tweet 12
  • SingTel annual profit more than halves on $2.3bn impairment charge

    47 shares
    Share 19 Tweet 12
American Dollar Exchange Rate
  • Advertise
  • Contact Us
  • Daily The Business
  • Privacy Policy
Write us: info@dailythebusiness.com

© 2021 Daily The Business

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Advertise
  • Contact Us
  • Daily The Business
  • Privacy Policy

© 2021 Daily The Business

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.